Similar results were obtained by Daponte et al. [22], who noted that survival of females with serous ovarian carcinoma, the cells of which demonstrated strong HIF-1α expression, was significantly abbreviated as compared to patients in whom neoplastic cells showed low or no HIF-1α expression. The gene discussed is HIF1A; the disease is ovarian serous carcinoma.